Kazia Therapeutics Limited
Last updated September 27, 2026
Organization details
- Legal name
- Kazia Therapeutics Limited
- Former names
- Novogen Ltd
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Australia
- Headquarters city
- Sydney NSW
- Headquarters country
- Australia
- Fiscal year end
- June
- Ticker symbol
- KZIA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001075880
Board of directors
-
Ebru Davidson · DirectorSince 2026
-
Robert F. Apple · DirectorSince 2026
-
Steven R. S. Coffey · DirectorSince 2026
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.